Belatacept Completed Phase 4 Trials for Nephrotoxicity Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02103855Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients